Page last updated: 2024-11-06

panaxatriol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Panaxatriol is a triterpene saponin found in the roots of ginseng (Panax ginseng). It is a major constituent of ginseng and has been shown to possess various pharmacological activities, including anti-inflammatory, antioxidant, and neuroprotective effects. The biosynthesis of panaxatriol involves a complex series of enzymatic reactions starting from squalene. Panaxatriol has been shown to inhibit the production of pro-inflammatory cytokines and to protect cells from oxidative stress. It has also been shown to improve cognitive function and memory in animal models. Panaxatriol is a promising candidate for the development of novel therapeutic agents for the treatment of various diseases. Research into panaxatriol is ongoing to further understand its mechanisms of action and its potential therapeutic applications.'

panaxatriol: a protopanaxatriol with the side chain cyclized into a pyran which is an artifact of acidic hydrolysis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73599
CHEMBL ID3391893
CHEBI ID169087
SCHEMBL ID467026
MeSH IDM0045679

Synonyms (27)

Synonym
(3s,5r,6r,8r,9r,10r,12r,13r,14r,17s)-4,4,8,10,14-pentamethyl-17-[(2r)-2,6,6-trimethyloxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3,6,12-triol
CHEBI:169087
panaxatriol
32791-84-7
dammarane-3,6,12-triol, 20,25-epoxy-, (3.beta.,6.beta.,12.beta.,20r)-
(3s,5r,6r,8r,9r,10r,12r,13r,14r,17s)-4,4,8,10,14-pentamethyl-17-[(2r)-2,6,6-trimethyltetrahydropyran-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3,6,12-triol
S3847
9f5b25fddg ,
(3beta,6alpha,12beta,20r)-20,25-epoxydammarane-3,6,12-triol
nsc 308880
unii-9f5b25fddg
panaxtriol
AKOS025311478
(3s,5r,6r,8r,9r,10r,12r,13r,14r,17s)-4,4,8,10,14-pentamethyl-17-((2r)-2,6,6-trimethyloxan-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta(a)phenanthrene-3,6,12-triol
(20r)-20,25-epoxydammarane-3.beta.,6.beta.,12.beta.-triol
CS-3847
SCHEMBL467026
Q-100403
HY-N0597
CHEMBL3391893
AC-8023
mfcd00210541
Q6635318
CCG-269510
DTXSID60954454
bdbm604162
us11660306, example panaxatriol

Research Excerpts

Overview

Panaxatriol (PT) is a natural product derived from ginseng that possesses cardioprotective effects in isolated rat hearts.

ExcerptReferenceRelevance
"Panaxatriol (PT) is a natural product derived from ginseng that possesses cardioprotective effects in isolated rat hearts. "( Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat.
Chen, P; Fu, H; Li, C; Li, M; Li, W; Pan, B; Shi, Y; Sun, G; Sun, X; Wang, J; Wang, Q; Wang, R; Wu, Q, 2020
)
2.27

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic (PK) is a bridge linking the herbal medicines and their pharmacological responses."( Pharmacokinetic Characterizations of Ginsenoside Ocotillol, RT5 and F11, the Promising Agents for Alzheimer's Disease from American Ginseng, in Rats and Beagle Dogs.
An, Y; Geng, C; Hu, H; Li, R; Li, Y; Li, Z; Liu, Y; Wang, Z; Xu, F; Zhang, B; Zhao, C, 2019
)
0.51
" The values of Cmax and AUC(0-t) indicated ocotillol type ginsenosides had low systemic exposure and poor absorption into blood."( Pharmacokinetic Characterizations of Ginsenoside Ocotillol, RT5 and F11, the Promising Agents for Alzheimer's Disease from American Ginseng, in Rats and Beagle Dogs.
An, Y; Geng, C; Hu, H; Li, R; Li, Y; Li, Z; Liu, Y; Wang, Z; Xu, F; Zhang, B; Zhao, C, 2019
)
0.51

Compound-Compound Interactions

ExcerptReferenceRelevance
" We hypothesized that panaxatriol (PT) derived from ginseng in combination with aerobic exercise (EX) may further promote protein synthesis and suppress protein degradation, and subsequently maintain muscle mass through the amelioration of insulin resistance."( Effects of Aerobic Exercise Combined with Panaxatriol Derived from Ginseng on Insulin Resistance and Skeletal Muscle Mass in Type 2 Diabetic Mice.
Fujita, S; Nomura, M; Takamura, Y; Uchiyama, A, 2017
)
1.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpenoid saponinA terpene glycoside in which the terpene moiety is a triterpenoid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1578190Cytotoxicity against Sprague-Dawley rat cardiomyocytes assessed as inhibition of cell growth at 10 uM treated for 50 hrs by MTT assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat.
AID1578191Cytoprotective activity against OGD/reperfusion induced injury in Sprague-Dawley rat cardiomyocytes assessed as effect on cell viability at 0.1 uM pretreated for 24 hrs followed by OGD for 2 hrs and subsequent reperfusion for 24 hrs (Rvb = 43.9 to 45.4 +/2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat.
AID1674942Binding affinity to recombinant human His-tagged CK-MM at 20 uM by Biolayer Interferometry analysis2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Structure-activity relationship analysis of dammarane-type natural products as muscle-type creatine kinase activators.
AID1674941Activation of human CK-MM assessed as increase in enzyme activity at 5 to 80 uM2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Structure-activity relationship analysis of dammarane-type natural products as muscle-type creatine kinase activators.
AID1578188Cytoprotective activity against OGD/reperfusion induced injury in Sprague-Dawley rat cardiomyocytes assessed as effect on cell viability at 10 uM pretreated for 24 hrs followed by OGD for 2 hrs and subsequent reperfusion for 24 hrs (Rvb = 43.9 to 45.4 +/-2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat.
AID1578189Cytoprotective activity against OGD/reperfusion induced injury in Sprague-Dawley rat cardiomyocytes assessed as effect on cell viability at 1 uM pretreated for 24 hrs followed by OGD for 2 hrs and subsequent reperfusion for 24 hrs (Rvb = 43.9 to 45.4 +/- 2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat.
AID1578185Cardioprotective activity in Sprague-Dawley rat model of LAD coronary artery ligation-induced ischemia/reperfusion assessed as infarct size of left ventricle size at 40 mg/kg, ig pretreated twice a day for 3 days and measured 24 hrs post-reperfusion by TT2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (8.51)18.7374
1990's14 (29.79)18.2507
2000's6 (12.77)29.6817
2010's18 (38.30)24.3611
2020's5 (10.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.79 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (95.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]